Browsing Tag

peripheral neuropathy

NeuroMetrix® Announces Launch of DPNCheck® 2.0, its Fast, Accurate, Quantitative Screening Test for…

Jason Junior Jan 24, 2023

WOBURN, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the commercial availability of DPNCheck 2.0, the Company's latest point-of-care device that leverages gold-standard nerve conduction…

Health

CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion,…

Jason Junior May 27, 2022

New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Chemotherapy-Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Steroids,…

Health

Pembrolizumab Scores Approval for Early Triple-Negative Breast Cancer

Jason Junior Jul 28, 2021

The FDA granted full approval to the PD-1 inhibitor pembrolizumab (Keytruda) plus chemotherapy for neoadjuvant treatment of high-risk…